Advance-ruling mechanism governs pending GST classification, exemption and taxability disputes, limiting writ review once the specialised forum functi...
Charitable trust income application permits verified capital expenditure but rejects deferred pre-operative claims and requires reconsideration of con...
Reinsurance premium deductions require established regulatory breaches, while independently acquired software qualifies within the computer depreciati...
Seven new Standard Input Output Norms under the Chemical and Allied Products group prescribe permitted import inputs and quantities for specified export products, including theophylline, liraglutide injection, lumefantrine, meropenem formulations and ophthalmic solutions. The norms specify relevant bulk drugs, chemicals and sterile bulk materials as allowable inputs; for ophthalmic solutions, bulk-drug content must conform to the Drug Manufacturing Licence. The new entries enable Regional Authorities to issue Advance Authorisations directly in eligible cases without individual referral to the Norms Committee, promoting faster processing and uniform norm fixation.
Seven new Standard Input Output Norms under the Chemical and Allied Products group prescribe permitted import inputs and quantities for specified export products, including theophylline, liraglutide injection, lumefantrine, meropenem formulations and ophthalmic solutions. The norms specify relevant bulk drugs, chemicals and sterile bulk materials as allowable inputs; for ophthalmic solutions, bulk-drug content must conform to the Drug Manufacturing Licence. The new entries enable Regional Authorities to issue Advance Authorisations directly in eligible cases without individual referral to the Norms Committee, promoting faster processing and uniform norm fixation.
Note: It is a system-generated summary and is for quick reference only.